Results 1 to 10 of about 85,259 (288)

In vitro detection of canine anti-human antibodies following intratumoral injection of the hu14.18-IL2 immunocytokine in spontaneous canine melanoma. [PDF]

open access: yesPLoS ONE
BackgroundCanine and human malignant melanoma are naturally occurring cancers with many similarities, making the dog an important parallel patient population to study both diseases.
Andrew T Kosharek   +6 more
doaj   +2 more sources

Development and evaluation of neutralizing antibodies for cross-protection against West Nile virus and Japanese encephalitis virus

open access: yesInfectious Medicine, 2023
Background: West Nile virus is a severe zoonotic pathogen that can cause severe central nervous system symptoms in humans and horses, and is fatal for birds, chickens and other poultry. With no specific drugs or vaccines available, antibody-based therapy
Meng-Jie Yang   +8 more
doaj   +1 more source

A Review of Therapeutic Antibodies in Breast Cancer

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2021
Since the first production of monoclonal antibodies about 35 years ago, researchers have found them useful in the treatment and diagnosis of various diseases such as cancer.
Maryam Eini   +4 more
doaj   +1 more source

Unique allergen-specific human IgE monoclonal antibodies derived from patients with allergic disease

open access: yesFrontiers in Allergy, 2023
IntroductionAllergic reactions are mediated by human IgE antibodies that bind to and cross-link allergen molecules. The sites on allergens that are recognized by IgE antibodies have been difficult to investigate because of the paucity of IgE antibodies ...
Bryan R. E. Smith   +11 more
doaj   +1 more source

Human monoclonal antibodies and monoclonal antibody multispecificity [PDF]

open access: yesBritish Journal of Cancer, 1987
The majority of human anti-tumour monoclonal antibodies (Mabs) isolated to date have been disappointing. Firstly, they react or cross react with intracellular cytoskeletal proteins or nuclear antigens and therefore are of limited value as blood borne agents.
AM Campbell, P Whitford, RE Leake
openaire   +2 more sources

Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model. [PDF]

open access: yesPLoS ONE, 2016
Clostridium difficile (C. difficile) infection (CDI) is the main cause of nosocomial antibiotic-associated colitis and increased incidence of community-associated diarrhea in industrialized countries.
Hongyu Qiu   +17 more
doaj   +1 more source

New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?

open access: yesFrontiers in Immunology, 2022
Nephrotic proteinuria is the hallmark of several glomerulonephritis determined by different pathogenetic mechanisms, including autoimmune, degenerative and inflammatory.
Biswanath Basu   +5 more
doaj   +1 more source

A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models. [PDF]

open access: yesPLoS ONE, 2010
Rabbit antibodies have been widely used in research and diagnostics due to their high antigen specificity and affinity. Though these properties are also highly desirable for therapeutic applications, rabbit antibodies have remained untapped for human ...
Yanlan Yu   +13 more
doaj   +1 more source

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab

open access: yesFrontiers in Immunology, 2020
Membranous Nephropathy (MN) is an autoimmune disease associated with antibodies against podocyte proteins: M-type phospholipase A2 receptor (PLA2R1) or thrombospondin type-1 domain-containing 7A (THSD7A) in 70 and 3% of patients, respectively.
Sonia Boyer-Suavet   +13 more
doaj   +1 more source

Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases

open access: yesFrontiers in Immunology, 2022
Current treatments for central nervous system (CNS) inflammatory demyelinating diseases (IDDs) include corticosteroids, plasma exchange, intravenous immunoglobulin, and immunosuppressant drugs.
Li Jiao, Shougang Guo, Shougang Guo
doaj   +1 more source

Home - About - Disclaimer - Privacy